SVP Clinical Development Jeffrey Wiezorek sold $85K of Kite Pharma, Inc.

Sold$85,343

$56.90Price

1,500Shares

−9%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Mon, Aug 1. Filed Tue, Aug 2, 2:51 PM ET, during the session. Not investment advice.